Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple ...
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Alphabet: One Of My Top Picks For The Next 5 Years
Alphabet's core business and other ventures present significant upside, with potential to double the stock price and ...